All Roads Lead To Change

All Roads Lead To Change

Addressing Unmet Needs in the African American MS Community

Program provided by MSAA and its educational partners

Providers as Champions of Research Registration

You Are Invited to a LIVE CME/CNE/ACE CE/CCMC Webcast:

All Roads Lead to Change: Addressing Unmet Needs in the African American MS Community.

Jointly provided by

Postgraduate Institute for Medicine     Multiple Sclerosis Association of America      Impact Education, LLC

This program is supported by independent educational grants from Biogen, Genentech, Inc., Novartis Pharmaceuticals Corporation and Sanofi Genzyme.

All Roads Lead to Change: Addressing Unmet Needs in the African American MS Community

Webcast 1: Providers as Champions of Research


Live Webcast Date






February 25, 2021

8:00 PM – 9:00 PM ET


Target Audience

This initiative is intended for neurologists, MS subspecialists, primary care clinicians, ER providers, registered nurses, social workers, case managers, other health care professionals involved in treatment and management of black patients with MS.

Program Overview

Incidence rates of MS have been found to be higher in both black males and black females versus white males and white females. Disease progression is also significantly faster in black MS patients in both brain and retinal measures. Furthermore, African Americans are dying from MS at an earlier age, which suggests that MS burden weighs disproportionately across race demographics.

These observations suggest a need to identify and address barriers to appropriate MS care experienced by African American patients. Efforts to lower and overcome these and other barriers require recognition of the gaps in care as well as behavioral changes within the MS treater community to minimize initial treatment delays and attenuate disease progression.

Educational Objectives

After completing this activity, the participant should be better able to: 

  • Recognize the importance of representation of African Americans in clinical trials.
  • Characterize how diverse representation in clinical trials positively affects patients living with various medical conditions.
  • Describe how patients may learn more about clinical trial participation.

 Expert Faculty Presenters:


Annette Howard, MD
Medical Director
Multiple Sclerosis Institute of Texas

Annette Okai, MD
Medical Director
Baylor Scott & White Multiple Sclerosis Treatment Center, Dallas

Jacqueline Faulkner Rosenthal, MD
Clinical Neurologist
Andrew C. Carlos Multiple Sclerosis Institute at Shepherd Center, Atlanta



8:00-8:05 p.m.   Pre-Activity Learning Assessment and Opening Comments/Overview
Annette Howard, MD
8:05-8:25 p.m. The Importance of Representation in Clinical Trials
Annette Okai, MD
8:25-8:45 p.m. Achieving Appropriate Representation in Clinical Trials
Jacqueline Rosenthal, MD
8:45-8:55 p.m.    Audience Q&A Session
8:55-9:00 p.m.   Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation

Accreditation Information

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, Multiple Sclerosis Association of America, and Impact Education, LLC.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Social Work Education

As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.  Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 cultural competency continuing education credits.

Case Manager Continuing Education

This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 1 CE contact hour(s). Activity code: I00045208 Approval Number: 210000576

To claim these CEs, log into your CCMC Dashboard at

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Fee Information

There is no fee for this educational activity.

If you have any questions, please call (215) 619-8812 or email